Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Journal of Diabetes and Its Complications|June 23, 2018
Sex differences in neuropathic pain in longstanding diabetes: Results from the Canadian Study of Longevity in Type 1 DiabetesNancy Cardinez, Leif E Lovblom, Johnny-Wei Bai, et al.
Diabetes Care|February 21, 2016
Association Between Plasma Uric Acid Levels and Cardiorenal Function in Adolescents With Type 1 DiabetesYuliya Lytvyn, Farid H Mahmud, Denis Daneman, et al.
Canadian Journal of Diabetes|November 9, 2023
Fasted C-Peptide Distribution and Associated Clinical Factors in Adults With Longstanding Type 1 Diabetes: Analysis of the Canadian Study of Longevity in Type 1 DiabetesSebastien O Lanctôt, Leif Erik Lovblom, Evan J H Lewis, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 26, 2019
Renal Hemodynamic Function and RAAS Activation Over the Natural History of Type 1 DiabetesYuliya Lytvyn, Petter Bjornstad, Julie A Lovshin, et al.
Diabetes, Obesity & Metabolism|February 15, 2019
Association between uric acid, renal haemodynamics and arterial stiffness over the natural history of type 1 diabetesYuliya Lytvyn, Petter Bjornstad, Julie A Lovshin, et al.
American Journal of Physiology. Renal Physiology|November 17, 2017
Dapagliflozin in focal segmental glomerulosclerosis: a combined human-rodent pilot studyHarindra Rajasekeran, Heather N Reich, Michelle A Hladunewich, et al.
Diabetes Care|February 14, 2018
Adiposity Impacts Intrarenal Hemodynamic Function in Adults With Long-standing Type 1 Diabetes With and Without Diabetic Nephropathy: Results From the Canadian Study of Longevity in Type 1 DiabetesPetter Bjornstad, Julie A Lovshin, Yuliya Lytvyn, et al.
Diabetes, Obesity & Metabolism|October 13, 2018
The relationships between markers of tubular injury and intrarenal haemodynamic function in adults with and without type 1 diabetes: Results from the Canadian Study of Longevity in Type 1 DiabetesPetter Bjornstad, Sunita K Singh, Janet K Snell-Bergeon, et al.
Hypertension (Dallas, Tex. : 1979)|December 5, 2025
Cardiovascular-Kidney Effects of Dapagliflozin in Patients at Cardiovascular Risk With or Without Type 2 Diabetes: Results of a Randomized, Double-Blind, Placebo-Controlled TrialVikas S Sridhar, Luxcia Kugathasan, Yuliya Lytvyn, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 12, 2025
Efficacy, Mechanisms and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Kidney Transplant Recipients: A Randomized, Double-Blind, Placebo-Controlled TrialVikas S Sridhar, Luxcia Kugathasan, Yuliya Lytvyn, et al.
Pageof 8